KLRS
Kalaris Therapeutics, Inc.
2.90$
-4.9%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| 171.2% | -12,215.2% | – | – | – | – | – | – | |
| – | 11.5% | – | – | – | – | – | – | |
| 300.1% | 845.5% | – | – | – | – | – | – | |
| 0.0% | 205.5% | – | – | – | – | – | – | |
| – | -39,178.2% | – | – | – | – | – | – | |
| -881.1% | – | – | – | – | – | – | – | |
| 2,015.2% | 73,286.7% | – | – | – | – | – | – | |
| 2,199.1% | 21,893.3% | – | – | – | – | – | – | |
| 171.2% | -12,420.6% | – | – | – | – | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.